RT @SurreyVet: 👏Congratulations #CharlotteMcCarroll @UniOfSurrey for publishing her work @ESC_Journals on inhibition of myocardial catheps…

RT @SurreyVet: 👏Congratulations #CharlotteMcCarroll @UniOfSurrey for publishing her work @ESC_Journals on inhibition of myocardial catheps…

RT @chris_loughrey: Delighted by our paper out this month with clinical colleagues from @jubilleeHospital @ColinBerryMD @BHFCoREGlasgow and…

RT @chris_loughrey: Delighted by our paper out this month with clinical colleagues from @jubilleeHospital @ColinBerryMD @BHFCoREGlasgow and…

RT @SurreyVet: 👏Congratulations #CharlotteMcCarroll @UniOfSurrey for publishing her work @ESC_Journals on inhibition of myocardial catheps…

RT @SurreyVet: 👏Congratulations #CharlotteMcCarroll @UniOfSurrey for publishing her work @ESC_Journals on inhibition of myocardial catheps…

👏Congratulations #CharlotteMcCarroll @UniOfSurrey for publishing her work @ESC_Journals on inhibition of myocardial cathepsin-L release during reperfusion folowing myocardial infarction improves cardiac funtion and reduces infarct size. For more info | h

RT @chris_loughrey: Delighted by our paper out this month with clinical colleagues from @jubilleeHospital @ColinBerryMD @BHFCoREGlasgow and…

Delighted by our paper out this month with clinical colleagues from @jubilleeHospital @ColinBerryMD @BHFCoREGlasgow and @OxfordBRC @UniofOxford demonstrating the beneficial effects of inhibiting myocardial cathepsin-L release following a heart attack http

RT @SurreyVet: 👏Congratulations #CharolotteMcCarroll @uniofsurrey for publishing her work in @ESC_Journals on Inhibition of myocardial cath…

RT @SurreyVet: 👏Congratulations #CharolotteMcCarroll @uniofsurrey for publishing her work in @ESC_Journals on Inhibition of myocardial cath…

👏Congratulations #CharolotteMcCarroll @uniofsurrey for publishing her work in @ESC_Journals on Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size https://t.co/1

RT @chris_loughrey: Delighted to see published our new translational study on the potential benefits of using cathepsin-L inhibitors to cou…

RT @UofGICAMS: We are delighted to see @chris_loughrey article "Translational study on the potential benefits of using cathepsin-L inhibito…

We are delighted to see @chris_loughrey article "Translational study on the potential benefits of using cathepsin-L inhibitors to counteract the deleterious effects" published by Oxford University Press in #cardiovascular #research . Read more➡️https://t.

RT @kenneth_mangion: Great output from a great collaboration including @chris_loughrey and @ColinBerryMD - Could Cathepsin-L be a novel ta…

RT @kenneth_mangion: Great output from a great collaboration including @chris_loughrey and @ColinBerryMD - Could Cathepsin-L be a novel ta…

RT @zaeri99: Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuN…

RT @kenneth_mangion: Great output from a great collaboration including @chris_loughrey and @ColinBerryMD - Could Cathepsin-L be a novel ta…

RT @kenneth_mangion: Great output from a great collaboration including @chris_loughrey and @ColinBerryMD - Could Cathepsin-L be a novel ta…

RT @zaeri99: Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuN…

Great output from a great collaboration including @chris_loughrey and @ColinBerryMD - Could Cathepsin-L be a novel target to counteract cardiac dysfunction after PPCI? #CardioTwitter #Cardiology #whycmr @DavidCarrick14 @matthewmylee @mbmcentegart @P_Rocc

RT @zaeri99: Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuN…

peep it 👀

RT @tamara_p_martin: So happy to see published our work on cathepsin-L inhibitors to limit reperfusion injury following ischemic heart dise…

RT @chris_loughrey: Delighted to see published our new translational study on the potential benefits of using cathepsin-L inhibitors to cou…

So happy to see published our work on cathepsin-L inhibitors to limit reperfusion injury following ischemic heart disease https://t.co/nusOkbEMta

RT @zaeri99: Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuN…

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size https://t.co/9EORynjyTG

RT @zaeri99: Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuN…

Glad to be part of published paper related to cardiac reperfusion injury. @chris_loughrey @Dylan_O'Tool @tamara_p_martin @StuNicklin @BahaUniversity @FAMS_BU https://t.co/tNBG9xDq9x

RT @chris_loughrey: Delighted to see published our new translational study on the potential benefits of using cathepsin-L inhibitors to cou…

https://t.co/Vc6lwqeY3K

Delighted to see published our new translational study on the potential benefits of using cathepsin-L inhibitors to counteract the deleterious effects of acute reperfusion injury after a heart attack. https://t.co/Fg2oeE0JSL